Target Name: GPALPP1
NCBI ID: G55425
Other Name(s): GPAM1_HUMAN | GPALPP motifs-containing protein 1 (isoform a) | GPALPP motifs containing 1 | lipopolysaccharide-specific response protein 7 | AD029 | Lipopolysaccharide-specific response protein 7 | GPALPP motifs containing 1, transcript variant 2 | KIAA1704 | Lipopolysaccharide specific response-7 protein | RP11-245H20.2 | bA245H20.2 | GPALPP motifs-containing protein 1 | GPALPP1 variant 2 | lipopolysaccharide specific response-7 protein | LSR7

GPAM1 as A Potential Drug Target Or Biomarker

GPALPP1 (GPAM1_HUMAN) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 6 and encodes a protein known as GPAM1, which is a key regulator of the growth and development of tissues in the body.

GPAM1 is expressed in a wide range of tissues and cells in the body, including the brain, pancreas, and gastrointestinal tract. It is involved in the regulation of cell growth, cell death, and cell-cell adhesion, and is thought to play a role in the development and progression of many diseases, including cancer.

Studies have suggested that GPAM1 may be a potential drug target or biomarker for a variety of diseases, including cancer. For example, researchers have found that high levels of GPAM1 are associated with poor prognosis in patients with pancreatic cancer, and that inhibiting GPAM1 may be a promising new approach to treating this disease.

In addition to its potential as a drug target or biomarker, GPAM1 is also of interest as a potential biomarker for certain diseases. For example, researchers have found that GPAM1 levels are elevated in the blood of people with colorectal cancer, and that these levels may be a useful diagnostic marker for this disease.

Furthermore, GPAM1 is also a potential target for drug development in other diseases, such as cardiovascular disease and neurodegenerative diseases.

In conclusion, GPALPP1 (GPAM1_HUMAN) is a gene that has the potential to be a drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand its role and to develop safe and effective treatments for the associated conditions.

Protein Name: GPALPP Motifs Containing 1

More Common Targets

GPAM | GPANK1 | GPAT2 | GPAT3 | GPAT4 | GPATCH1 | GPATCH11 | GPATCH2 | GPATCH2L | GPATCH3 | GPATCH4 | GPATCH8 | GPBAR1 | GPBP1 | GPBP1L1 | GPC1 | GPC1-AS1 | GPC2 | GPC3 | GPC4 | GPC5 | GPC5-AS1 | GPC5-AS2 | GPC6 | GPC6-AS1 | GPC6-AS2 | GPCPD1 | GPD1 | GPD1L | GPD2 | GPER1 | GPHA2 | GPHB5 | GPHN | GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21 | GPR22 | GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34